Rankings
▼
Calendar
LQDA Q2 2018 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena
LQDA
Liquidia Corporation
$3B
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
-47.4% YoY
Gross Profit
$948,537
91.0% margin
Operating Income
-$7M
-667.4% margin
Net Income
-$6M
-601.1% margin
EPS (Diluted)
$-0.41
QoQ Revenue Growth
+12.6%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$8M
Stock-Based Comp.
$519,835
Balance Sheet
Total Assets
$21M
Total Liabilities
$34M
Stockholders' Equity
-$13M
Cash & Equivalents
$9M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$2M
-47.4%
Gross Profit
$948,537
$2M
-50.1%
Operating Income
-$7M
-$6M
-10.8%
Net Income
-$6M
-$8M
+24.4%
Revenue Segments
Collaboration And Licensing Non Refundable Upfront Payments
$943,419
87%
Research And Development Services
$99,460
9%
Collaboration And Licensing Milestones
$45,058
4%
← FY 2018
All Quarters
Q3 2018 →